Report Details:
15 Companies Covered
90 Pages
Market Research Future (MRFR) has published a cooked research report on the “Global Medical Tourism Market” that contains information from 2019 to 2035.
The Medical Tourism Market is estimated to register a CAGR of 18.02% during the forecast period of 2024 to 2035.
MRFR recognizes the following companies as the key players in the Global Medical Tourism Market — include Apollo Hospitals Enterprise Ltd, Bumrungrad International Hospital, Bangkok Hospital, Raffles Medical Group, Asklepios Kliniken GmbH & Co. KGaA, Mount Elizabeth Hospitals, Medanta – The Medicity, Manipal Health Enterprises Pvt. Ltd., Fortis Healthcare Ltd, Samitivej Hospital and Others.
Medical Tourism Market Highlights
The Medical Tourism Market is estimated to register a CAGR of 18.02% during the forecast period and is estimated to reach USD 2,92,866.10 Million by 2035.
The rising awareness about medical tourism among patients has become one of the most influential forces shaping the global healthcare landscape. Over the past decade, access to information has dramatically improved through the internet, social media platforms, digital healthcare directories, and specialized medical tourism agencies. Patients are far more informed about their treatment options, healthcare costs, and potential outcomes, enabling them to make cross-border healthcare decisions with greater confidence. Unlike in the past, when medical tourism was viewed as a niche choice, it has now gained mainstream acceptance across different patient demographics, particularly among those seeking affordable care, quicker procedures, and high-quality medical services abroad.
Several factors contribute to this growing awareness. Firstly, the increasing prevalence of patient testimonials, reviews, and success stories shared online fosters trust in overseas healthcare facilities. Platforms dedicated to medical tourism provide comprehensive information about hospitals, doctors, treatment packages, travel logistics, and accommodation, which makes the process more transparent and accessible. Additionally, government campaigns such as India’s “Heal in India,” Thailand’s “Amazing Thailand Health & Wellness,” and Malaysia’s Healthcare Travel Council have played a pivotal role in promoting the credibility of their healthcare systems, thereby enhancing international patient confidence. In September 2025, The Assembly approved the Rajasthan University of Health Sciences (Amendment) Bill, 2025, enabling the establishment of the Rajasthan Institute of Medical Sciences (RIMS) in Jaipur. RIMS will enhance advanced healthcare infrastructure, attract global patients through specialized and cost-effective treatments, and position Rajasthan as a leading hub for medical tourism growth
Rising awareness is also closely linked to growing dissatisfaction with healthcare systems in developed countries, where high treatment costs and long waiting times push patients to explore alternatives abroad. As more patients share positive cross-border treatment experiences, others become motivated to pursue similar opportunities.
Segment Analysis
The Global Immuno-oncology assay Market has been segmented based on By Treatment type, By , By Technology, By service provider , By region.
Based on treatment type, the global medical tourism market has been segmented into orthopaedic, ophthalmology, oncology, cosmetic surgery, epilepsy, cardiovascular, dentistry, neurology, fertility, and others. Dentistry further segmented into dental implants, orthodontics, dental cosmetics, and others. The Cosmetic Surgery segment held the largest market share in 2024, and Fertility is the fastest-growing segment during the forecast period i.e., 2025 -2035.
The ophthalmology in the medical tourism industry is growing rapidly, driven by rising global demand for low-cost, high-quality eye care. Countries such as India, Thailand, Turkey, Mexico, and the UAE have established themselves as top destinations by providing modern procedures such as LASIK, cataract surgery, and corneal transplants at substantially lower costs than Western markets. These countries use cutting-edge technology, internationally approved facilities, and multilingual medical practitioners to attract international patients looking for both quality and value.
Hospitals and leading eye centers are investing in advanced diagnostic and surgical devices including femtosecond lasers, premium intraocular lenses, and AI-powered imaging systems. Furthermore, the combination of teleophthalmology and digital patient platforms improves pre- and post-operative treatment, as well as the overall patient experience. The sector also benefits from increased awareness generated by focused medical tourism marketing and government-backed initiatives that encourage specialized care hubs. For instance, in August 2021, Bascom Palmer launched rapid virtual eye care that established excellent clinical care practices. This innovative initiative enables patients to interact with clinical providers via laptop, smartphone, or tablet for a virtual consultation on their eye and vision issues.
Based on service providers, the global medical tourism market has been segmented into public and private. The Private segment held the largest market share in 2024 and the same is the fastest-growing segment during the forecast period i.e., 2025 -2035.
Public service providers are playing an increasingly critical role in shaping and scaling medical tourism, particularly in nations with government-supported infrastructure that facilitates international patient interaction. In Malaysia, the Malaysia Healthcare Travel Council (MHTC), which is part of the Ministry of Health, has established the country as an industry leader by combining regulatory control, worldwide branding, and patient facilitation on a single platform. MHTC actively assists public and commercial hospitals through accreditation alignment, digital marketing, and worldwide collaboration. In Turkey, USHAŞ (International Health Services Inc.) is a government-established body that coordinates international health services, oversees quality standards, promotes Turkish healthcare abroad, and helps public hospitals better manage foreign patients. In India, the Rajasthan state government launched the "Heal in Rajasthan" initiative, in July 2025 which involves upgrading public hospitals to meet global care benchmarks, training personnel in hospitality and medical ethics, and facilitating international patient travel through dedicated liaison cells and dispute-resolution frameworks. South Korea's "Medical Korea" initiative, led by the Korea Health Industry Development Institute (KHIDI), also offers a structured government-led platform for certifying providers, promoting national healthcare abroad, and assisting foreign patients with travel coordination and hospital selection via multilingual support centers located at major transportation hubs. These government-led approaches not only improve worldwide competitiveness, but they also build trust in national healthcare systems by ensuring standardization, safety, and patient rights across both public and private providers.
Private healthcare providers are using innovation and expansion to increase their worldwide appeal in the medical tourism industry. Apollo Hospitals had a strong Q4 performance, with a 13% increase in healthcare services revenue and approximately ₹4 billion in net profit. The company expects to add 4,300 beds over the next three to four years to accommodate rising demand, including international patients. Their digital healthcare and pharmacy branch (Apollo HealthCo) experienced a strong 17% increase, indicating an accelerated shift toward integrated care-forward models. Furthermore, Apollo's leadership is campaigning for expedited medical visas, pressing the government to implement enhanced e-visa facilities similar to Thailand and Singapore, as part of the broader 'Heal in India' initiative to eliminate entry friction and optimize inflows of medical tourists. Moreover, Bumrungrad International Hospital in Thailand demonstrated its dedication to providing superior treatment for more than a million patients each year by obtaining its third Global Healthcare Accreditation (GHA) with "Excellence," a rare 100% score across all assessed criteria. Additionally, the organization is growing by opening a brand-new, cutting-edge facility in Phuket that is designed to draw in both foreign and expatriate patients looking for premium medical care in a picturesque location.
Regional Analysis
Based on region, the global medical tourism market has been segmented into North America, Europe, Asia-Pacific, and Rest of the World. Asia-Pacific accounted for the largest market share in 2024 and is projected to grow at the highest CAGR of 19.31% during the forecast period.
The North America immuno-oncology assay market accounted for USD 1,662.05 Billion in 2024 and is projected to grow at a CAGR of 9.87% during the forecast period. Europe is further segmented into the US, and Canada.
The North America medical tourism market accounted for USD 8,879.36 million in 2024 and is projected to grow at a CAGR of 16.06% during the forecast period. North America is further segmented into the US and Canada.
The North America medical tourism sector has shifted rapidly in responses to continuously high domestic healthcare costs, insurance gaps, and challenges to timely access. Mexico has emerged as a popular destination for Americans seeking lower-cost dental and cosmetic services, both to geographic proximity and government efforts to promote health travel. In contrast, the United States, despite being an appealing location for medical tourists, attracts inbound patients seeking highly specialized care in oncology, cardiology, and advanced surgeries, offered by world-class facilities. Anecdotal evidence suggests that a retired US couple flew to Thailand, Vietnam, Mexico, and the Caribbean for cancer treatment for a cost of USD 18,807, saving almost USD 100,000 compared to US prices and bypassing Medicare constraints. A US patient chose a USD 4,000 hysterectomy in Colombia over a USD 15,000 to USD 40,000 treatment in the US. They cited economical, high-quality care, full English assistance, and debt-free recovery. Despite these benefits, safety remains an important concern. Prior to the COVID-19 outbreak, some 400,000 Americans sought medical operations in Mexico each year.
Key Findings of the Study
- The Global Medical Tourism Market is expected to reach USD 2,92,866.10 Million by 2035, at a CAGR of 18.02% during the forecast period.
- The Asia Pacific region accounted for the fastest growth in the global market.
- Based on By Treatment type , the cosmetic surgery segment was attributed to holding the largest market in 2024.
- Apollo Hospitals Enterprise Ltd, Bumrungrad International Hospital, Bangkok Hospital, Raffles Medical Group, Asklepios Kliniken GmbH & Co. KGaA, Mount Elizabeth Hospitals, Medanta – The Medicity, Manipal Health Enterprises Pvt. Ltd., Fortis Healthcare Ltd, Samitivej Hospital and Others and Others are the key market players.